Inactive Instrument

TAIO PHAR Japan Exchange

Equities

4581

JP3442850008

Otemon Co., Ltd. completed the acquisition of 73.12% stake in Taisho Pharmaceutical Holdings Co., Ltd. for approximately ¥520 billion.

January 14, 2024

Otemon Co., Ltd. made an offer to acquire Taisho Pharmaceutical Holdings Co., Ltd. (TSE:4581) for ¥8620 on November 24, 2023. Daiwa Securities Ltd. provided Due Diligence to Taisho Pharmaceutical Holdings Co., Ltd

Otemon Co., Ltd. completed the acquisition of 73.12% stake in Taisho Pharmaceutical Holdings Co., Ltd. (TSE:4581) for approximately ¥520 billion on January 15, 2024. DC Advisory acted as financial advisor to Taisho Pharmaceutical Holdings Co., Ltd.

Latest news about TAIO PHAR

Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank...

May. 13

Chart TAIO PHAR

Duration

Period

More charts

Company Profile

Taisho Pharmaceutical Holdings Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products, and ethical drugs. The Company operates in two business segments. The Self-Medication segment is engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of ethical drugs. The other business is engaged in the leasing and management of real estate, as well as hotel management business.

Sector

Calendar

2024-07-31 - Q1 2024 Earnings Release (Projected)

More about the company